1.Rossano, JW, Dipchand, AI, Edwards, LB, et al. The registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Heart Transplantation Report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant 2016; 35: 1185–1195.
2.Gossett, JG, Canter, CE, Zheng, J, et al. Decline in rejection in the first year after pediatric cardiac transplantation: a multi-institutional study. J Heart Lung Transplant 2010; 29: 625–632.
3.Mills, RM, Naftel, DC, Kirklin, JK, et al. Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database. J Heart Lung Transplant 1997; 16: 813–821.
4.Kobashigawa, JA. The search for a gold standard to detect rejection in heart transplant patients: are we there yet? Circulation 2017; 135: 936–938.
5.Costanzo, MR, Dipchand, A, Starling, R, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010; 29: 914–956.
6.Wagner, K, Oliver, MC, Boyle, GJ, et al. Endomyocardial biopsy in pediatric heart transplant recipients: a useful exercise? (Analysis of 1,169 biopsies). Pediatr Transplant 2000; 4: 186–192.
7.Levi, DS, DeConde, AS, Fishbein, MC, Burch, C, Alejos, JC, Wetzel, GT. The yield of surveillance endomyocardial biopsies as a screen for cellular rejection in pediatric heart transplant patients. Pediatr Transplant 2004; 8: 22–28.
8.Rosenthal, DN, Chin, C, Nishimura, K, et al. Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data. J Heart Lung Transplant 2004; 23: 323–329.
9.Godown, J, Harris, MT, Burger, J, Dodd, DA. Variation in the use of surveillance endomyocardial biopsy among pediatric heart transplant centers over time. Pediatr Transplant 2015; 19: 612–617.
10.Bhat, G, Burwig, S, Walsh, R. Morbidity of endomyocardial biopsy in cardiac transplant recipients. Am Heart J 1993; 125: 1180–1181.
11.Baraldi-Junkins, C, Levin, HR, Kasper, EK, Rayburn, BK, Herskowitz, A, Baughman, KL. Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant 1993; 12: 63–67.
12.Pophal, SG, Sigfusson, G, Booth, KL, et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999; 34: 2105–2110.
13.Ye, XT, Parker, A, Brink, J, Weintraub, RG, Konstantinov, IE. Cost-effectiveness of the National Pediatric Heart Transplantation Program in Australia. J Thorac Cardiovasc Surg 2018.
14.Dodd, DA, Brady, LD, Carden, KA, Frist, WH, Boucek, MM, Boucek, RJ Jr. Pattern of echocardiographic abnormalities with acute cardiac allograft rejection in adults: correlation with endomyocardial biopsy. J Heart Lung Transplant 1993; 12: 1009–1017.
15.Valantine, HA, Yeoh, TK, Gibbons, R, et al. Sensitivity and specificity of diastolic indexes for rejection surveillance: temporal correlation with endomyocardial biopsy. J Heart Lung Transplant 1991; 10: 757–765.
16.Moran, AM, Lipshultz, SE, Rifai, N, et al. Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection. J Heart Lung Transplant 2000; 19: 756–764.
17.Boucek, MM, Mathis, CM, Boucek, RJ Jr., et al. Prospective evaluation of echocardiography for primary rejection surveillance after infant heart transplantation: comparison with endomyocardial biopsy. J Heart Lung Transplant 1994; 13: 66–73.
18.Tantengco, MV, Dodd, D, Frist, WH, Boucek, MM, Boucek, RJ. Echocardiographic abnormalities with acute cardiac allograft rejection in children: correlation with endomyocardial biopsy. J Heart Lung Transplant 1993; 12: S203–210.
19.Boucek, RJ Jr., Boucek, MM, Asante-Korang, A. Advances in methods for surveillance of rejection. Cardiol Young 2004; 14 Suppl 1: 93–96.
20.Asante-Korang, A, Fickey, M, Boucek, MM, Boucek, RJ Jr. Diastolic performance assessed by tissue Doppler after pediatric heart transplantation. J Heart Lung Transplant 2004; 23: 865–872.
21.Pauliks, LB, Pietra, BA, DeGroff, CG, et al. Non-invasive detection of acute allograft rejection in children by tissue Doppler imaging: myocardial velocities and myocardial acceleration during isovolumic contraction. J Heart Lung Transplant 2005; 24: S239–S248.
22.Putzer, GJ, Cooper, D, Keehn, C, Asante-Korang, A, Boucek, MM, Boucek, RJ Jr. An improved echocardiographic rejection-surveillance strategy following pediatric heart transplantation. J Heart Lung Transplant 2000; 19: 1166–1174.
23.Stewart, S, Winters, GL, Fishbein, MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710–1720.
24.Berry, GJ, Angelini, A, Burke, MM, et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant 2011; 30: 601–611.
25.Everitt, MD, Donaldson, AE, Casper, TC, et al. Effect of ABO-incompatible listing on infant heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) database. J Heart Lung Transplant 2009; 28: 1254–1260.
26.Zinn, MD, Wallendorf, MJ, Simpson, KE, Osborne, AD, Kirklin, JK, Canter, CE. Impact of routine surveillance biopsy intensity on the diagnosis of moderate to severe cellular rejection and survival after pediatric heart transplantation. Pediatr Transplant 2018; 22: e13131.
27.Everitt, MD, Pahl, E, Schechtman, KB, et al. Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: a multi-institutional study. J Heart Lung Transplant 2011; 30: 282–288.
28.Zinn, MD, Wallendorf, MJ, Simpson, KE, Osborne, AD, Kirklin, JK, Canter, CE. Impact of age on incidence and prevalence of moderate-to-severe cellular rejection detected by routine surveillance biopsy in pediatric heart transplantation. J Heart Lung Transplant 2017; 36: 451–456.
29.Dipchand, AI, Rossano, JW, Edwards, LB, et al. The registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Pediatric Heart Transplantation Report-2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 2015; 34: 1233–1243.
30.Weckbach, LT, Maurer, U, Schramm, R, et al. Lower frequency routine surveillance endomyocardial biopsies after heart transplantation. PLoS One 2017; 12: e0182880.
31.Winters, GL, Loh, E, Schoen, FJ. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted? Circulation 1995; 91: 1975–1980.
32.Winters, GL, McManus, BM. Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists. J Heart Lung Transplant 1996; 15: 728–735.
33.Yang, HM, Lai, CK, Gjertson, DW, et al. Has the 2004 revision of the International Society of Heart and Lung Transplantation grading system improved the reproducibility of the diagnosis and grading of cardiac transplant rejection? Cardiovasc Pathol 2009; 18: 198–204.
34.Brunner-La Rocca, HP, Sutsch, G, Schneider, J, Follath, F, Kiowski, W. Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation. Circulation 1996; 94: 1334–1338.
35.Sethi, GK, Kosaraju, S, Arabia, FA, Roasdo, LJ, McCarthy, MS, Copeland, JG. Is it necessary to perform surveillance endomyocardial biopsies in heart transplant recipients? J Heart Lung Transplant 1995; 14: 1047–1051.
36.Chin, C, Akhtar, MJ, Rosenthal, DN, Bernstein, D. Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart transplantation. J Pediatr 2000; 136: 238–242.
37.Zinn, M, Simpson, K, Wallendorf, M, Osborne, A, Kirklin, J, Canter, C. Impact of routine surveillance biopsy intensity on the diagnosis of moderate to severe cellular rejection and survival after pediatric heart transplant. J Heart Lung Transplant 2016; 35: S406.
39.Auerbach, SR, Gralla, J, Campbell, DN, Miyamoto, SD, Pietra, BA. Steroid avoidance in pediatric heart transplantation results in excellent graft survival. Transplantation 2014; 97: 474–480.
40.Singh, TP, Faber, C, Blume, ED, et al. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients. J Heart Lung Transplant 2010; 29: 517–522.